<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//explicyte.kipdev-s2.com/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://explicyte.kipdev-s2.com/</loc>
		<lastmod>2026-07-03T07:26:15+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/Oncology-target-discovery-CRO-services-based-on-FFPE-tissues.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/preclinical-oncology-services-CRO.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/translational-CRO-services-in-oncology-biomarker-analysis-in-trials.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/service-provider-white.svg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/ISO9001-13485-explicyte-biomarker-services.svg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/about/commitments-csr/</loc>
		<lastmod>2026-07-23T15:03:57+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/cell-based-assays/t-cell-mediated-tumor-killing-assays/</loc>
		<lastmod>2026-07-23T14:23:09+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Imane-nafia.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/T-cell-activation-immune-checkpoint-inhibition-killing-assays-CRO-in-vitro-services.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/immune-cell-tumor-killing-assay-CRO-services-atezolizumab-promotes-immune-cell-response-1024x652-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/tumor-killing-assay-services-CRO-Atezolizumab-anti-tumor-immune-cell-activity-1024x405-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/immune-checkpoint-blockade-PBMC-tumor-killing-1024x772-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/T-cell-killing-assay-CRO-invitro-screening-CD8-T-A375-melanom-cells.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/cell-based-assays/antigen-specific-killing/</loc>
		<lastmod>2026-07-23T14:14:12+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Imane-nafia.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Tumor-antigen-specific-T-cell-killing-assay-CRO-immuno-oncology.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/about/</loc>
		<lastmod>2026-07-23T13:59:02+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/service-provider-white.svg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/ISO9001-13485-explicyte-biomarker-services.svg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Alban-Bessede.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Imane-nafia.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Jean-Philippe-Guegan.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/loic-cerf.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/about/careers-immuno-oncology-jobs-bordeaux-france/</loc>
		<lastmod>2026-07-22T14:14:44+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Explicyte-team-2026-web.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Atera-single-cell-spatial-whole-transcriptome.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2019/03/explicyte-immuno-oncology-bergonie-institut-cancer-centrer-cro-translational.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/</loc>
		<lastmod>2026-07-22T08:23:13+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/immune-mediated-tumor-killing-assays-CRO-services-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/immune-function-modulation-assays-CRO-service-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/cytokine-release-assays-CRS-risks-CRO-services.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/patient-derived-3D-tumor-models-organoids-fragments-oncology-CRO.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/multispecifics-t-cell-engager-assays-oncology-CRO-services.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/ADC-antibody-drug-conjugate-assays-oncology-CRO-services.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/cancer-vaccines-assays-oncology-CRO-services.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/patient-derived-3d-tumor-models/</loc>
		<lastmod>2026-07-22T08:22:01+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Imane-nafia.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Early-immune-native-TNBC-PDOs.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Early-immune-native-TNBC-PDOs-are-immunotherapy-responsive-1536x459.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/2-day-CRC-tumor-fragment.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/tumor-immune-infiltration-CRC-tumor-fragment-1536x1086.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Native-immune-cells-in-CRC-tumor-fragments-are-modulated-under-immunotherapy.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Immune-native-CRC-fragments-are-functionally-responsive-to-immunotherapy.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/cell-based-assays/</loc>
		<lastmod>2026-07-22T08:07:11+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/tumor-killing-assay-CRO-services-3.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/t-cell-mediated-tumor-kiling-assay-CRO-services-explicyte.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Tumor-antigen-specific-T-cell-killing-assays.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/ADCC-assay-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/T-cell-activation-assay.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/immune-cell-migration.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/cytokine-release-assays-CRS-risks-CRO-services.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/macrophage-assays-CRO-services.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/MLR-assay-CRO-service.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Germinal-center-assay-B-cell-CRO-services.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/contact/</loc>
		<lastmod>2026-07-20T14:09:32+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/explicyte-immuno-oncology-bergonie-institut-cancer-centrer-cro-translational-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/explicyte-immuno-oncology-CRO-cancer-immunotherapy-Bordeaux-France-Europe-1.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/multiomics/</loc>
		<lastmod>2026-07-20T09:30:26+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/Single-cell-and-spatial-biology-services-1-1024x683.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/cellular-molecular-profiling-multi-omics-CRO-1024x683.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/service-provider-white-b.svg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/ISO9001-13485-explicyte-biomarker-services-b.svg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/explicyte-multiomics-transcriptomics-CRO-team-1024x710.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/terms/</loc>
		<lastmod>2026-07-17T16:14:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/legal-notice-and-website-terms-of-use/</loc>
		<lastmod>2026-07-17T15:57:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/discovery/ffpe-cohort-sourcing/</loc>
		<lastmod>2026-07-17T15:24:53+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/Marie-Brevet.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/Lucile-Vanhersecke-pathologist-768x767-1.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/privacy-policy/</loc>
		<lastmod>2026-07-17T15:01:05+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/cell-based-assays/direct-killing/</loc>
		<lastmod>2026-07-15T08:55:37+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/cell-based-assays/adcc-assay/</loc>
		<lastmod>2026-07-15T08:54:40+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Imane-nafia.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/ADCC-assay-antibody-dependent-cell-cytotoxicity-NK-tumor-killing-CRO-services.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/ADCC-assays-Flow-cytometry-evaluation-expression-target-tumor-antigens-NK-CD16-receptor-1024x370-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/ADCC-assay-CRO-Promotion-of-IFNg-release-by-activated-NK-cells.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/ADCC-tumor-killing-assay-NK-cells-in-vitro-services-CRO.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/ADCC-tumor-killing-assay-NK-cells-in-vitro-efficacy-CRO.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/cell-based-assays/immune-cell-activation/</loc>
		<lastmod>2026-07-09T09:20:09+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Imane-nafia.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/immune-cell-activation-assay-NK-T-cells-PBMC-CRO-services-immuno-oncology-efficacy-studies-1-1536x674-1.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/PBMC-activation-assay-CRO-immuno-oncology-cytokine-release-e1716483514138.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/immune-cell-activation-assays-PD1-immune-checkpoint-inhibitors-cancer-immunotherapy.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/CRO-cancer-immunotherapy-L-Kynurenine-limits-CD4-t-cells-in-vitro-services-e1716483562518.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/cell-based-assays/germinal-center-reaction/</loc>
		<lastmod>2026-07-09T08:30:54+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/TLS-cell-based-assay-CRO-immuno-oncology.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Imane-nafia.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Tertiary-Lymphoid-Structures-TLS-assay-CRO-services-cancer-immunotherapies-1536x674-1.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/co-culture-T-Follicular-Helper-Memory-B-Cells-TLS-assay-CRO-immuno-oncology-1024x716-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/TLS-assay-immune-checpoint-inhibitors-PDL1-PDL1-CTLA4.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Tertiary-Lymphoid-Structures-activation-cell-based-assay.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/cell-based-assays/immune-cell-migration/</loc>
		<lastmod>2026-07-08T13:51:57+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Imane-nafia.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/immune-cell-migration-assays-chemotaxis-cancer-immunotherapy-t-cells-neutrophils-1-1024x450.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/T-cell-migration-assays-chemotaxis-CRO-services-1024x331-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/tumor-infitrating-neutrophils-TAMS-migration-assay-cancer-immunotherapy-services-2-1-e1716484050575.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/cell-based-assays/macrophage-polarization/</loc>
		<lastmod>2026-07-08T13:01:02+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Imane-nafia.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/M2-Macrophage-Suppression-Assay-CRO-immuno-oncology-immunotherapy-2-1024x588.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/marker-expression-cytokinic-profile-of-M1-M2-macrophages-flow-cytometry-1024x737-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/M2-macrophage-assay-CRO-immunosuppression-mediating-pathway-inhibitors-1-1024x286-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/macrophage-assay-Immune-checkpoint-blockade-M1-M2-1024x535-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/cell-based-assays/mixed-lymphocyte-reaction/</loc>
		<lastmod>2026-07-08T09:37:54+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/MLR-assays-immuno-oncology-CRO-services-1024x806-1.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Imane-nafia.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/MLR-assay-CRO-services-cancer-immunotherapy-in-vitro-cell-based-assays.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/MLR-assay-immune-checkpoint-inhibitors.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/MLR-assay-adenosine-CRO-cancer-immunotherapy.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/trials/</loc>
		<lastmod>2026-07-02T09:41:05+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/Transcriptomic-biomarker-analysis-clinical-trials-oncology-CRO-services-1024x576.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/target-expression-profiling-ffpe-tissues-oncology-cro-1024x576.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/peripheral-biomarker-analysis-blood-samples-FAQS-proteomics-metabolomics-scrnaseq-1024x576.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/service-provider-white.svg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/ISO9001-13485-explicyte-biomarker-services.svg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/clinical-sample-management-oncology-trial-CRO.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/oncology-clinical-trial-biomarker-analysis-services-CRO.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/07/Clinical-trial-biomaker-data-analysis-services.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/discovery/</loc>
		<lastmod>2026-06-26T10:24:10+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/Custom-FFPE-tissue-sourcing-oncology-CRO-1024x576.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/FFPE-Transcriptomic-profiling-data-science-oncology-target-discovery-1024x576.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/target-expression-profiling-ffpe-tissues-oncology-cro-1024x576.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/service-provider-white.svg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/ISO9001-13485-explicyte-biomarker-services.svg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/discovery/ai-ready-spatial-datasets/</loc>
		<lastmod>2026-06-24T16:19:06+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/discovery/ffpe-target-expression/</loc>
		<lastmod>2026-06-23T17:06:37+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/cancer-target-prevalence-ffpe-tissues-staining-intensity-H-score.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/oncology-target-localization-compartment-specificity-CRO-services.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/plugins/elementor/assets/images/placeholder-v4.svg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/plugins/elementor/assets/images/placeholder-v4.svg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/discovery/ffpe-transcriptomics/</loc>
		<lastmod>2026-06-23T15:47:21+00:00</lastmod>
		<image:image>
			<image:loc>https://explicyte.kipdev-s2.com/wp-content/uploads/2026/06/team-explicyte-contacts-1024x658.jpg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/multiomics/bioinformatics/</loc>
		<lastmod>2026-06-15T08:47:08+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/resources/</loc>
		<lastmod>2026-06-12T13:59:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/resources/posters-abstracts/</loc>
		<lastmod>2026-06-12T13:14:06+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/resources/io-target-database/</loc>
		<lastmod>2026-06-12T12:35:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/resources/oncology-case-studies/</loc>
		<lastmod>2026-06-12T08:44:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/resources/oncology-events-webinars/</loc>
		<lastmod>2026-06-12T08:16:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/resources/publications/</loc>
		<lastmod>2026-06-12T08:15:15+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/resources/news-press/</loc>
		<lastmod>2026-06-12T08:08:29+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/multiomics/platforms/spatial-biology/</loc>
		<lastmod>2026-05-27T16:44:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/multiomics/platforms/liquid-sample-profiling/</loc>
		<lastmod>2026-05-27T16:43:26+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/multiomics/platforms/liquid-sample-profiling/single-cell-rnaseq/</loc>
		<lastmod>2026-05-27T16:43:14+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/multiomics/platforms/liquid-sample-profiling/olink-proteomics/</loc>
		<lastmod>2026-05-27T16:43:09+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/multiomics/platforms/liquid-sample-profiling/multiplexed-flow-cytometry/</loc>
		<lastmod>2026-05-27T16:42:59+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/multiomics/platforms/10x-genomics/</loc>
		<lastmod>2026-05-27T16:42:11+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/multiomics/platforms/</loc>
		<lastmod>2026-05-27T16:41:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/trials/transcriptomic-biomarkers/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/trials/peripheral-biomarker-analysis/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/sitemap/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/trials/iso-certified-pathology/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/multiomics/platforms/10x-genomics/xenium/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/cell-based-assays/immune-function-modulation/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/trials/iso-certified-pathology/ihc-if-assay-development/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/multiomics/platforms/10x-genomics/visium-hd/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/privacy/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/trials/iso-certified-pathology/ihc-if-assay-validation/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/multiomics/platforms/10x-genomics/chromium-x/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/trials/iso-certified-pathology/multiplex-if-tls-scoring/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/multiomics/platforms/spatial-biology/geomx/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/multiomics/platforms/spatial-biology/digital-pathology/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/safety-immunogenicity/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/safety-immunogenicity/cytokine-release/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/modality-specific-assays/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/modality-specific-assays/antibody-drug-conjugates/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/cell-based-assays/tumor-killing-assays/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/modality-specific-assays/multispecifics-t-cell-engagers/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/multiomics/bioinformatics/10x-datasets/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/modality-specific-assays/cancer-vaccines/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/multiomics/bioinformatics/bulk-rnaseq-geomx-datasets/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/oncology-cro-services/preclinical/cell-based-assays/tumor-killing-assays/sensitization/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/multiomics/bioinformatics/mif-ihc-image-analysis/</loc>
		<lastmod>2026-05-27T15:34:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://explicyte.kipdev-s2.com/sample-page/</loc>
		<lastmod>2026-05-26T22:17:00+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Rank Math SEO Plugin (c) Rank Math - rankmath.com -->